Cytotoxicity of hydroxyapatite, fluorapatite and fluor-hydroxyapatite: A comparative in vitro study

Neoplasma

Volumn 55, Issue 4, 2008, Pages 312-316

  Theiszova, M ^a   Jantova, S ^a   Letasiova, S ^a   Palou, M ^a   Cipak, L ^b  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Apoptosis; Cytotoxicity; Fluor hydroxyapatite; Fluorapatite; Hydroxyapatite

Indexed keywords

BIOMATERIAL; CASPASE 3; CASPASE 9; FLUORAPATITE; FLUORHYDROXYAPATITE; HYDROXYAPATITE; UNCLASSIFIED DRUG; APATITE; DRUG CARRIER; FLUOR HYDROXYLAPATITE; FLUOR-HYDROXYLAPATITE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; IN VITRO STUDY; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; ANIMAL; CELL SURVIVAL; DRUG EFFECT; DRUG SCREENING; LEUKEMIA L 1210; MATERIALS TESTING; METABOLISM;

ANIMALS; APATITES; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CASPASE 3; CASPASE 9; CELL PROLIFERATION; CELL SURVIVAL; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; DURAPATITE; HYDROXYAPATITES; LEUKEMIA L1210; MATERIALS TESTING; MICE;

EID: 42749090657     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. SUN JS, LIN FH, HUNG TY et al. The influence of hydroxyapatite particles on osteoclast cell activities. J Biomed Mater Res 1999; 1: 27-34.
2. ITOKAZU M, AOKI T, NONOMURA H et al. Antibioticloaded porous hydroxyapatite blocks for the treatment of osteomyelitis and postoperative infection. A preliminary report. Bull Hosp Jt Dis 1998; 57: 125-129. (Pubitemid 28509427)
3. XIA Q, NIE H, CHEN D et al. The effect of locally implanted complexes of adriamycin-hydroxyapatite complexes on tumor-study of a new alternative treatment for hepatic cancer. J Tongji Med Univ 1999; 19: 219-222.
4. UCHIDA A, SHINTO Y, ARAKI N, ONO K. Slow release of anticancer drugs from porous calcium hydroxyapatite ceramic. J Orthop Res 1992; 3: 440-445.
5. YAMAMURA K, IWATA H, OSADO T et al. Anticancer effects of adriamycin-loaded hydroxyapatite implants determined in a swarm rat chondrosarcoma model. Jpn J Pharmacol 1994; 3: 289-291.
6. TAHAR Y, ISHII Y. Apatite cement containing cis-diamminedichloroplatinum implanted in rabbit femur for sustained release of the anticancer drug and bone formation. J Orthop Sci 2001; 6: 556-565.
7. LIU ZS, TANG SL, AI ZL. Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells. World J Gastroenterol 2003; 9: 1968-1971. (Pubitemid 37168423)
8. INAYAT-HUSSAIN SH, RAJAB NF, ROSLIE H et al. Cell death induced by hydroxyapatite on L929 fibroblast cells. Med J Malaysia 2004; 59B: 176-177.
9. FU Q, ZHOU N, HUANG W et al. Preparation and characterization of novel bioactive bone cement: Glass based nanoscale hydroxyapatite bone cement. J Mater Sci 2004; 15: 1333-1338. (Pubitemid 40385331)
10. CHEN X, DENG CH, TANG S, ZHANG M. Mitochondriadependent apoptosis induced by nanoscale hydroxyapatite in human gastric cancer SGC-7901 cells. Biol Pharm Bull. 2007; 1: 128-132. (Pubitemid 46066332)
11. GROSS KA, RODRIGUEZ-LORENZO LM. Sintered hydroxyfluorapatites. Part I: Sintering ability of precipitated solid solution powders, Biomaterials 2004; 25: 1375-1384.
12. BERRY CC, WELLS S, CHARLES S, CURTIS AS. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003; 24: 4551-4557.
13. KUZIELOVA E, PALOU MT. Microstructure development of fluor-hydroxyapatite solid solution during the sintering. VI Proceeding of conference on preparation of ceramic materials 2005; 16-17.
14. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 143: 265-267.
15. THEISZOVA M, JANTOVA S, DRAGUNOVA J et al. Comparison the cytotoxicity of hydroxyapatite measured by direct cell counting and MTT test in murine fibroblast NIH-3T3 cells. Biomed Pap Med 2005; 2: 393-396.